Filing Details

Accession Number:
0001140361-15-045998
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-30 20:00:39
Reporting Period:
2015-12-29
Filing Date:
2015-12-30
Accepted Time:
2015-12-30 20:00:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827809 Qlt Inc QLTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376960 Jason Aryeh C/O Qlt Inc.
887 Great Northern Way, Suite 250
Vancouver A1 V5T 4T5
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2015-12-29 18,000 $2.50 461,078 No 4 P Indirect By JALAA Equities, LP
Common Shares Acquisiton 2015-12-29 400 $2.49 461,478 No 4 P Indirect By JALAA Equities, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By JALAA Equities, LP
No 4 P Indirect By JALAA Equities, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 74,000 Direct
Footnotes
  1. Securities are owned by JALAA Equities, LP, of which Jason Aryeh is the General Partner. By reason of the provisions of Rule 16a-1 under the Securities Exchange Act of 1934, as amended, Mr. Aryeh may be deemed to be the beneficial owner of the securities owned by JALAA Equities, LP.